Atossa Genetics Conference Call and Webcast Notice
(firmenpresse) - SEATTLE, WA -- (Marketwired) -- 10/04/13 -- (NASDAQ: ATOS), The Breast Health Company™, will host a conference call at 5:45 pm Eastern Time today to discuss the Company's voluntary recall of its ForeCYTE Breast Health Test; Mammary Aspiration Specimen Cytology Test (MASCT) System, which was announced today at 5:00 pm Eastern Time.
To listen to the call by phone, interested parties within the U.S. may dial 866-652-5200. International callers should dial 412-317-6060. All callers should ask for the Atossa Genetics conference call. The conference call will also be available through a live webcast at .
A replay of the call will be available one hour after the end of the call through November 4, 2013, and can be accessed via Atossa's website or by dialing 877-344-7529 (domestic) or 412-317-0088 (international). The replay conference ID number is 10034877.
Atossa Genetics, Inc. is focused on the commercialization of patented, diagnostic medical devices and, through its wholly-owned subsidiary, The National Reference Laboratory for Breast Health, Inc. (NRLBH), patented, laboratory developed tests designed to assess breast health.
The NRLBH is a CLIA-certified high-complexity molecular diagnostic laboratory located in Seattle, Washington.
For additional information, on Atossa and the NRLBH, please visit and .
Atossa Genetics, Inc.
Kyle Guse
CFO and General Counsel
(O) 800-351-3902
MBS Value Partners
Matthew D. Haines (Investors)
Managing Director
(O) 212-710-9686
JQA Partners
Jules Abraham (Media)
Principal
917-885-7378
Themen in dieser Pressemitteilung:
Unternehmensinformation / Kurzprofil:
Datum: 04.10.2013 - 15:01 Uhr
Sprache: Deutsch
News-ID 1269826
Anzahl Zeichen: 0
contact information:
Contact person:
Town:
SEATTLE, WA
Phone:
Kategorie:
Healthcare
Anmerkungen:
Diese Pressemitteilung wurde bisher 167 mal aufgerufen.
Die Pressemitteilung mit dem Titel:
"Atossa Genetics Conference Call and Webcast Notice
"
steht unter der journalistisch-redaktionellen Verantwortung von
Atossa Genetics, Inc. (Nachricht senden)
Beachten Sie bitte die weiteren Informationen zum Haftungsauschluß (gemäß TMG - TeleMedianGesetz) und dem Datenschutz (gemäß der DSGVO).
